Micrus Endovascular Company Profile

20:30 EST 10th December 2018 | BioPortfolio

Micrus Endovascular is a medical device company formed in June 1996 with its corporate headquarters in San Jose, California. Micrus Endovascular manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Our products are used by interventional neuroradiologists and neurosurgeons primarily to treat cerebral aneurysms in the brain responsible for hemorrhagic stroke, a significant cause of death in the United States. The Micrus product line is an endovascular system that enables a physician to gain access to the brain in a minimally invasive manner through the vessels of the circulatory system. We believe our products provide a safe and reliable alternative to more invasive neurosurgical procedures for treating aneurysms. Our proprietary, three-dimensional microcoils are unique in that they automatically deploy within the aneurysm, forming a scaffold that conforms to a wide diversity of aneurysm shapes and sizes. We also sell accessory devices and products used in conjunction with our microcoils. We rely extensively on our physician advisors to advise on our research and development efforts and to provide feedback on the clinical use of our products. Our advisors includes experts in interventional neuroradiology and cerebral vascular diseases. We regularly consult with our physician advisors regarding our research and development efforts, preclinical trials and clinical trials.


821 Fox Lane
San Jose
United States of America


Phone: (408) 433-1400
Fax: (408) 433-1401

News Articles [54 Associated News Articles listed on BioPortfolio]

‘Smart sheath’ uses AI to detect bleeds during endovascular procedures

A New Jersey hospital is testing an artificial intelligence (AI) device designed to alert clinicians to bleeding episodes during endovascular procedures.

Cerus Endovascular Expands Intellectual Property Portfolio

FREMONT, Calif. and OXFORD, England, Nov. 27, 2018 /PRNewswire/ -- Cerus Endovascular Ltd., a privately held medical device company engaged in the design and development Read more...

Endologix Broadens Recall to All AFX Endovascular AAA Systems

The company is recalling all AFX endovascular aortic aneurysm systems after continued problems with type III endoleaks. The FDA has now classified the recall as class I, the most serious designation. ...

Vivasure introduces PerQseal large-bore closure device in Europe

Novel transcatheter endovascular procedures, including transcatheter aortic valve replacement (TAVR), thoracic endovascular aneurysm repair (TEVAR), and endovascular abdominal aneurysm repair (EVAR), ...

[Articles] Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

Estimated ischaemic core volume was independently associated with functional independence and functional improvement but did not modify the treatment benefit of endovascular thrombectomy over standard...

[Comment] Endovascular stenting in femoropopliteal arteries

Peripheral arterial disease (PAD) represents a major burden on public health worldwide. The number of affected patients has increased in both low-income and middle-income countries (by 28·7% for 2000...

Gore unveils first patient implant endovascular stent graft for ascending aorta

The GORE ascending stent graft features a delivery system that is designed to enable for accurate, controlled deployment in complex anatomies As part of Arise study, the implant The post Gore unveils...

Mid-and long-term efficacy of endovascular-based procedures for Cockett syndrome

Drugs and Medications [0 Results]


PubMed Articles [420 Associated PubMed Articles listed on BioPortfolio]

Endovascular Aneurysm Sealing of a Collapsed and Thrombosed Aortic Stent-Graft With Renovisceral Chimney Stent-Grafts.

To report the use of the Nellix endovascular aneurysm sealing (EVAS) system in the management of proximal stent-graft collapse associated with thrombosis following endovascular aneurysm repair (EVAR).

Endovascular Control of Pelvic Hemorrhage: Concomitant use of REBOA and Endovascular Intervention.

Reinterventions following endovascular revascularization in elderly with critical limb ischemia; an observational study.

Endovascular first strategy for critical limb ischemia is widely accepted, because of the increasing patency rates and minimal invasive character, especially in elderly patients. Nonetheless, the impa...

Fenestrated Endovascular Repair of Zones 1 and 2 Aortic Arch Pathologies.

and Design: Surgical management of aortic arch pathologies is complex, and endovascular developments have now enabled total or hybrid endovascular aortic arch repair. We present our early experience w...

Direct endovascular thrombectomy and bridging strategies for acute ischemic stroke: a network meta-analysis.

The present Bayesian network meta-analysis aimed to compare the various strategies for acute ischemic stroke: direct endovascular thrombectomy within the thrombolysis window in patients with no contra...

Clinical Trials [380 Associated Clinical Trials listed on BioPortfolio]

Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan RCT

The aim of this study is to clarify the efficacy of the endovascular treatment for acute ischemic stroke patients with large vessel occlusion and are not respond to intravenous recombinant...

MR-based Collateral Imaging to Predict Response to Endovascular Treatment of Stroke (FAST-COLL Study)

Based on the results of recent randomized controlled trials, current international guidelines recommend the initiation of endovascular treatment within 6 hours of symptom onset for acute i...

Endovascular Versus Open Repair of the Common Femoral Artery

Even though the indication for endovascular therapy has been enlarged, open repair of common femoral artery is still considered as the treatment of choice. A recent pilot study showed that...

Perfusion Imaging Evaluation for Ischemic Stroke on 6-24 Hours Undergoing Endovascular Thrombectomy

This study aims to evaluate the hypothesis that thrombectomy devices plus medical management leads to superior clinical outcomes in acute ischemic stroke patients at 90 days as compared to...

TX2® Low Profile TAA Endovascular Graft

The Zenith® TX2® Low Profile TAA Endovascular Graft study is a clinical trial approved by US FDA to evaluate the safety and effectiveness of the Zenith® TX2® Low Profile TAA Endovascul...

Companies [51 Associated Companies listed on BioPortfolio]

Micrus Endovascular Corporation

Micrus develops, manufactures and markets implantable and disposable medical devices for use in the treatment of cerebral vascular diseases. Micrus products are used by interventi...

Micrus Endovascular

Micrus Endovascular is a medical device company formed in June 1996 with its corporate headquarters in San Jose, California. Micrus Endovascular manufactures and markets both implantable and disposabl...

MAQUET Cardiovascular LLC

Patients with vascular conditions require flexible treatment options, including both traditional open vascular interventions and endovascular therapies. Current research indicates that surgeons use a ...

Aptus Endosystems, Inc.

Aptus Endosystems is a privately held medical technology company that has developed advanced technology for the endovascular treatment of aortic aneurysm disease. Founded in 2002,...


ev3 Inc. is a leading worldwide medical device company one hundred percent focused on catheter-based or endovascular technologies for the minimally invasive treatment of vascular disease and disorders...

More Information about "Micrus Endovascular" on BioPortfolio

We have published hundreds of Micrus Endovascular news stories on BioPortfolio along with dozens of Micrus Endovascular Clinical Trials and PubMed Articles about Micrus Endovascular for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Micrus Endovascular Companies in our database. You can also find out about relevant Micrus Endovascular Drugs and Medications on this site too.

Quick Search


Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Corporate Database Quicklinks

Searches Linking to this Company Record